Aevice Health

Aevice Health develops non-invasive wearable medical devices for continuous remote respiratory monitoring, enabling clinicians to gain insights into patients' respiratory conditions through continuous monitoring and auscultation. A MedTech spin-off from Nanyang Technological University, the company's wearable stethoscope can be attached to the body to measure heart rate, breathing rate, wheezing, and coughing using proprietary algorithms. The device provides a dashboard view with automated periodical reports, and the company also offers wearable patches designed for pediatric use to track health trends. Aevice Health targets chronic respiratory diseases including asthma and COPD, addressing one of the generation's biggest healthcare challenges by bringing seamless remote respiratory care to clinicians and patients. The platform enables value-based care through remote monitoring, allowing healthcare providers to track patient conditions between visits, detect exacerbations early, and reduce hospital readmissions. The company differentiates itself through its focus on non-invasive, continuous respiratory monitoring with proprietary algorithms for detecting wheezing and coughing patterns, rather than episodic monitoring or camera-based solutions. Founded in 2016 and headquartered in Singapore, Aevice Health has raised approximately $9.1 million in a Seed round backed by East Ventures, TOHO HOLDINGS, Silicon Solution Partners, AIP Private Capital, Pureland Group, HealthTEC, NTUitive, Coronet Ventures, SEEDS Capital, Denka, Elev8, Sing Hup Leong Investment, Chee Yam Contractor, and Highbury Capital.